Showing results (1-10 of 117) with videos related to
Sort By:
Pageof 12
Critical Reviews in Oncogenesis|April 5, 2012
Src kinase inhibitors: promising cancer therapeutics?Helen Creedon, Valerie G BruntonThe Biochemical Journal|September 9, 2014
The role and therapeutic potential of the autotaxin-lysophosphatidate signalling axis in breast cancerKaty Teo, Valerie G BruntonAdvances in Experimental Medicine and Biology|January 17, 2025
E-Cadherin-Mediated Cell-Cell Adhesion and Invasive Lobular Breast CancerEsme Bullock, Valerie G BruntonCurrent Opinion in Genetics & Development|January 16, 2002
Advances in Rho-dependent actin regulation and oncogenic transformationMargaret C Frame, Valerie G BruntonCurrent Opinion in Pharmacology|July 16, 2008
Src and focal adhesion kinase as therapeutic targets in cancerValerie G Brunton, Margaret C FrameExperimental Dermatology|July 2, 2019
Inhibition of cyclin-dependent kinase activity exacerbates H2 O2 -induced DNA damage in Kindler syndrome keratinocytesHila Emmert, Jayne Culley, Valerie G BruntonFree Radical Biology & Medicine|May 15, 2017
Kindlin-1 protects cells from oxidative damage through activation of ERK signallingHila Emmert, Hitesh Patel, Valerie G BruntonJournal of Cell Science|July 12, 2007
The membrane targeting and spatial activation of Src, Yes and Fyn is influenced by palmitoylation and distinct RhoB/RhoD endosome requirementsEmma Sandilands, Valerie G Brunton, Margaret C FrameBritish Journal of Cancer|November 26, 2020
The fibrotic and immune microenvironments as targetable drivers of metastasisLuke Boulter, Esme Bullock, Zeanap Mabruk, et al.Drug Discovery Today|April 12, 2012
Combining imaging and pathway profiling: an alternative approach to cancer drug discoveryNeil O Carragher, Valerie G Brunton, Margaret C FramePageof 12